Rezolute (RZLT) Shares Outstanding (2010 - 2026)

Rezolute (RZLT) posted Shares Outstanding (Entity) of $96.3 million for Q1 2026, up 0.78% sequentially from $95.5 million in Q4 2025, and up 59.05% YoY from $60.5 million in Q1 2025.

Rezolute (RZLT) Shares Outstanding (2010 - 2026) Analysis & Trends

Rezolute has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $96.3 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 59.05% year-over-year to $96.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $96.3 million (up 59.05% YoY) and the FY2025 annual result came in at $87.0 million, up 63.39% from the prior year.
  • Shares Outstanding (Entity) improved to $96.3 million in Q1 2026 per RZLT's latest filing, from $95.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $96.3 million in Q1 2026 and troughed at $15.6 million in Q1 2022.
  • A 5-year average of $59.2 million and a median of $51.4 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) surged 237118.09% in 2022, then fell 1.16% in 2024.
  • Over 5 years, Shares Outstanding (Entity) stood at $51.4 million in 2022, then dropped by 0.0% to $51.4 million in 2023, then climbed by 17.75% to $60.5 million in 2024, then jumped by 57.84% to $95.5 million in 2025, then rose by 0.78% to $96.3 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $96.3 million, $95.5 million, and $91.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.19 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.45 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 445.06 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.61 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Rezolute 442.94 Mn 442.94 Mn - 104.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 104.04 Mn
Dec 31, 2025 103.69 Mn
Sep 30, 2025 103.42 Mn
Jun 30, 2025 76.00 Mn
Mar 31, 2025 70.03 Mn
Dec 31, 2024 69.94 Mn
Sep 30, 2024 69.74 Mn
Jun 30, 2024 51.47 Mn
Mar 31, 2024 50.81 Mn
Dec 31, 2023 51.41 Mn
Sep 30, 2023 51.41 Mn
Jun 30, 2023 51.19 Mn
Mar 31, 2023 51.41 Mn
Dec 31, 2022 51.41 Mn
Sep 30, 2022 50.53 Mn
Jun 30, 2022 18.20 Mn
Mar 31, 2022 17.22 Mn
Dec 31, 2021 15.68 Mn
Sep 30, 2021 8.51 Mn
Jun 30, 2021 7,671.00